Brca1 and differentiation

Mutation Research - Reviews in Mutation Research

Volumn 512, Issue 2-3, 2002, Pages 165-172

  Kubista, Marion ^a   Rosner, Margit ^a   Miloloza, Angelina ^a   Hofer, Katja ^a   Prusa, Andrea Romana ^a   Kroiss, Regina ^a   Marton, Erika ^a   Hengstschläger, Markus ^a  

^a UNIVERSITY OF VIENNA   (Austria)

Author keywords

Brca1; Breast cancer; Differentiation; Mamma; Mammary epithelial cells

Indexed keywords

LIGAND; PROTEIN P53;

ALLELE; APOPTOSIS; BREAST CARCINOMA; CELL CYCLE; CELL DIFFERENTIATION; CELL PROLIFERATION; DISEASE ASSOCIATION; DNA REPAIR; GENE CONTROL; GENE EXPRESSION; GENE MUTATION; HUMAN; IMMUNOBLOTTING; KNOCKOUT MOUSE; NONHUMAN; ONCOGENE; OVARY CANCER; PRIORITY JOURNAL; REVIEW; TUMOR GROWTH; TUMOR SUPPRESSOR GENE; WILD TYPE;

MURINAE;

EID: 0036897971     PISSN: 13835742     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1383-5742(02)00063-7     Document Type: Review

References (47)

1. Welsch P.L., King M.-C. BRCA1 and BRCA2 and the genetics of breast and ovarian cancer. Hum. Mol. Genet. 10:2001;705-713.
2. Miki Y., Swensen J., Futureal D., Shattuck-Eidens P.A., Harshman K., Tavtigian S., Liu Q.Y., Cochran C., Bennett L.M., Ding W., Bell R., Rosental J., Hussey C., Tran T., Mcclure M., Frye C., Hattier T., Phelps R., Haugenstrano A., Katcher H., Yakumo K., Gholami Z., Shaffer D., Stone S., Bayer S., Skolnick M.H. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science. 266:1994;66-71.
3. Zheng L., Li S., Boyer T.G., Lee W.-H. Lessons learned from BRCA1 and BRCA2. Oncogene. 19:2000;6159-6175.
4. Wang Q., Zhang H., Fishel R., Greene M.I. BRCA1 and cell signalling. Oncogene. 19:2000;6152-6158.
5. Kerr P., Ashworth A. New complexities for BRCA1 and BRCA2. Curr. Biol. 11:2001;R668-R676.
6. Kinzler K.W., Vogelstein B. Cancer-susceptibility genes: gatekeepers and caretakers. Nature. 386:1997;761-763.
7. Venkitaraman A.R. Cancer susceptibility and the functions of BRCA1 and BRCA2. Cell. 108:2002;171-182.
8. Fan S., Wang J.-A., Yuan R., Ma Y., Meng Q., Erdos M.R., Pestell R.G., Yuan F., Auborn K.J., Goldberg I.D., Rosen E.M. BRCA1 inhibition of estrogen receptor signalling in transfected cells. Science. 284:1999;1354-1356.
9. Fan S., Ma Y.X., Wang C., Yuan R.-Q., Meng Q., Wang J.-A., Erdos M., Goldberg I.D., Webb P., Kushner P.J., Pestell R.G., Rosen E.M. Role of direct interaction in BRCA1 inhibition of estrogen receptor activity. Oncogene. 20:2001;77-87.
10. Zheng L., Annab L.A., Afshari C.A., Lee W.-H., Boyer T.G. BRCA1 mediates ligand-independent transcriptional repression of the estrogen receptor. Proc. Natl. Acad. Sci. U.S.A. 98:2001;9587-9592.
11. Fan S., Ma Y.X., Wang C., Yuan R.-Q., Meng Q., Wang J.-A., Erdos M., Goldberg I.D., Webb P., Ksuhner P.J., Pestell R.G., Rosen E.M. p300 modulates the BRCA1 inhibition of estrogen receptor activity. Cancer Res. 62:2002;141-151.
12. Bennett L.M., McAllister K.A., Malphurs J., Ward T., Collins N.K., Seely J.C., Gowen L.C., Koller B.H., Davis B.J., Wiseman R.W. Mice heterozygous for a Brca1 or Brca2 mutation display distinct mammary gland and ovarian phenotypes in response to diethylstilbestrol. Cancer Res. 60:2000;3461-3469.
13. Xu X., Wagner K.-U., Larson D., Weaver Z., Li C., Ried T., Henninghausen L., Wynshaw-Boris A., Deng C.-X. Conditional mutation of Brca1 in mammary epithelial cells results in blunted ductal morphogenesis and tumour formation. Nature Genet. 22:1999;37-43.
14. Kubista M., Rosner M., Kubista E., Bernaschek G., Hengstschläger M. Brca1 regulates in vitro differentiation of mammary epithelial cells. Oncogene. 21:2002;4747-4756.
15. Marquis S.T., Rajan J.V., Wynshaw-Boris A., Xu J., Yin G.Y., Abel K.J., Weber B.L., Chodosh L.A. The developmental pattern of Brca1 expression implies a role in differentiaiton of the breast and other tissues. Nat. Genet. 11:1995;17-26.
16. Lane T.F., Deng C., Elson A., Lyu M.S., Kozak C.A., Leder P. Expression of Brca1 is associated with terminal differentiation of ectodermally and mesodermally derived tissues in mice. Genes Dev. 9:1995;2712-2722.
17. Rajan J.V., Wang M., Marquis S.T., Chodosh L.A. Brca2 is coordinately regulated with Brca1 during proliferation and differentiation in mammary epithelial cells. Proc. Natl. Acad. Sci. U.S.A. 93:1996;13078-13083.
18. Rajan J.V., Marqhis S.T., Gardner H.P., Chodosh L.A. Developmental expression of Brca2 colocalizes with Brca1 and is associated with proliferation and differentiation in multiple tissues. Dev. Biol. 15:1997;385-401.
19. Blackshear P.E., Goldsworthy S.M., Foley J.F., McAllister K.A., Bennett L.M., Collins N.K., Bunch D.O., Brown P., Wiseman R.W., Davis B.J. Brca1, Brca2 expression patterns in mitotic and meiotic cells of mice. Oncogene. 16:1998;61-68.
20. Bernard-Gallon D.J., DeLatour M.P., Sylvain V., Vissac C., Aunoble B., Chassagne J., Bignon Y.J. Brca1 and Brca2 protein expression patterns in different tissues of murine origin. Int. J. Oncol. 18:2001;271-280.
21. Laud K., Hornez L., Gourdou I., Belair L., Arnold A., Peyrat J.P., Djiane J. Expression of BRCA1 gene in ewe mammary epithelial cells during pregnancy: regulation by growth hormone and steroid hormones. Eur. J. Endocr. 145:2001;763-770.
22. Mixon M., Kittrell F., Medina D. Expression of Brca1 and splice variant Brca1D11 RNA levels in mouse mammary gland during normal development and tumourigenesis. Oncogene. 19:2000;5237-5243.
23. Magdninier F., Venezia N.D., Lenoir G.M., Frappart L., Dante R. BRCA1 expression during prenatal development of the human mammary gland. Oncogene. 18:1999;4039-4043.
24. Huber L.J., Yang T.W., Sarkisian C.J., Master S.R., Deng C.-X., Chodosh L.A. Impaired DNA damage response in cells expressing an exon 11 deleted murine Brca1 variant that localizes to nuclear foci. Mol. Cell. Biol. 21:2001;4005-4015.
25. Gudas J., Li T., Nguyen H., Jensen D., Rauscher F.I., Cowan K. Cell cycle regulation of BRCA1 messenger RNA in human breast epithelial cells. Cell Growth Differ. 7:1996;717-723.
26. Vaughn J., Davis P., Jarboe M., Huber G., Evans A., Wiseman R., Berchuck A., Iglehart J., Futreal P., Marks J. BRCA1 expression is induced before DNA synthesis in both normal and tumour-derived breast cells. Cell Growth Differ. 7:1996;711-715.
27. Chen Y., Farmer A., Chen C.-F., Jones D., Chen P.-L., Lee W.-H. BRCA1 is a 230-kDa nuclear phosphoprotein that is expressed and phosphorylated in a cell cycle-dependent manner. Cancer Res. 56:1996;3168-3172.
28. Ruffner H., Verma I. BRCA1 is a cell cycle-regulated nuclear phosphoprotein. Proc. Natl. Acad. Sci. U.S.A. 94:1997;7138-7143.
29. Gudas J.M., Nguyen H., Li T., Cowan K.H. Hormone-dependent regulation of BRCA1 in human breast cancer cells. Cancer Res. 55:1995;4561-4565.
30. Spillman M.A., Bowcock A.M. BRCA1 and BRCA2 mRNA levels are coordinately elevated in human breast cancer cells in response to estrogen. Oncogene. 13:1996;1639-1645.
31. Marks J.R., Huper G., Vaughn J.P., Davis P.L., Norris J., McDonnell D.P., Wiseman R.W., Futreal P.A., Iglehart J.D. BRCA1 expression is not directly responsive to estrogen. Oncogene. 14:1997;115-121.
32. Romagnolo D., Annab L.A., Thompson T.E., Risinger J.I., Terry L.A., Barrett J.C., Afshari C.A. Estrogen, upregulation of BRCA1 expression with no effect on localization. Mol. Carcinogen. 22:1998;102-109.
33. MacMahon B., Cole P., Lin T.M., Lowe C.R., Mirra A.P., Ravnihar B., Salber E.J., Valaoras V.G., Yuasa S. Age at first birth and breast cancer risk. Bull. WHO. 43:1970;209-221.
34. Chodosh L.A., D'Cruz C.M., Gardner H.P., Ha S.I., Marquis S.T., Rajan J.V., Stairs D.B., Wang J.Y., Wang M. Mammary gland development, reproductive history, and breast cancer risk. Cancer Res. 59(Suppl.):1999;1765s-1772s.
35. Russo I.H., Russo J. Developmental stage of the rat mammary gland as determinant of its susceptibility to 7,12-dimethylben(a)anthracene. J. Natl. Cancer Inst. 61:1978;1439-1449.
36. Brodie S.G., Deng C.-X. BRCA1-associated tumourigenesis: what have we learned from knockout mice? Trends Genet. 17:2001;18-22.
37. Gowen L.C., Johnson B.L., Latour A.M., Sulik K.K., Koller B.H. Brca1 deficiency results in early embryonic lethality characterized by neuroeopithelial abnormalities. Nat. Genet. 12:1996;191-194.
38. Hakem R., de la Pompa J.L., Sirard C., Mo R., Woo M., Hakem A., Wakeham A., Potter J., Reitmair A., Billia F., Firpo E., Hui C.C., Roberts J., Rossant J., Mak T.W. The tumour suppressor gene Brca1 is required for embryonic cellular proliferation in the mouse. Cell. 85:1996;1009-1023.
39. Liu C.Y., Flesken-Nikitin A., Li S., Zeng Y., Lee W.H. Inactivation of the mouse Brca1 gene leads to failure in the morphogenesis of the egg cylinder in early postimplantation development. Genes Dev. 10:1996;1835-1843.
40. Ludwig T., Chapman D.L., Papaioannou V.E., Efstratiadis A. Targeted mutations of breast cancer susceptibility gene homologs in mice: lethal phenotypes of Brca1, Brca2, Brca1/Brca2, Brca1/p53, and Brca2/p53 nullizygous embryos. Genes Dev. 11:1997;1226-1241.
41. Shen S.X., Weaver Z., Xu X., Li C., Weinstein W., Guan X.Y., Ried T., Deng C.X. A targeted disruption of the murine Brca1 gene causes y-radiation hypersensitivity and genetic instability. Oncogene. 17:1998;3115-3124.
42. Xu X., Weaver Z., Linke S.P., Li C., Gotay J., Wang X.W., Harris C.C., Ried T., Deng C.X. Centrosome amplification and a defective G2-M cell cycle checkpoint induce genetic instability in BRCA1 exon 11 isoform-deficient cells. Mol. Cell. 3:1999;389-395.
43. Ludwig T., Fisher P., Ganesan S., Efstratiadis A. Tumourigenesis in mice carrying a truncating Brca1 mutation. Genes Dev. 15:2001;1188-1193.
44. Osborne C.K., Zhao H., Fuqua S.A. Selective estrogen receptor modulators: structure, function, and clinical use. J. Clin. Oncol. 18:2000;3172-3186.
45. Brown P.H., Lippman S.M. Chemoprevention of breast cancer. Breast Cancer Res. Treat. 62:2000;1-17.
46. Perlman T., Evans R.M. Nuclear receptors in Sicily: all in the famiglia. Cell. 90:1977;391-397.
47. Welsch P.L., Lee M.K., Gonzalez-Hernandez R.M., Black D.J., Mahadevappa M., Swisher E.M., Warrington J.A., King M.-C. BRCA1 transcriptionally regulates genes involved in breast tumourigenesis. Proc. Natl. Acad. Sci. U.S.A. 99:2002;7560-7565.